Shaolin Capital Management’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-72,032
Closed -$7.33M 563
2021
Q2
$7.33M Buy
72,032
+61,903
+611% +$6.27M 0.23% 98
2021
Q1
$1.02M Sell
10,129
-9,871
-49% -$1.01M 0.04% 308
2020
Q4
$2.2M Buy
20,000
+6,737
+51% +$716K 0.15% 156
2020
Q3
$1.39M Sell
13,263
-6,737
-34% -$698K 0.11% 148
2020
Q2
$2.04M Buy
20,000
+6,000
+43% +$596K 0.19% 110
2020
Q1
$1.37M Buy
+14,000
New +$1.39M 0.19% 103

Other funds holding CELU

Shaolin Capital Management's CELU Position: Q3 2021 in Review

Shaolin Capital Management sold out of Celularity (CELU) in Q3 2021, closing a stake of 72,032 shares — an estimated $7.33M sold.

Shaolin Capital Management first reported a position in CELU in Q1 2020 and held it in 6 quarters. The position peaked at $7.33M in Q2 2021. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Shaolin Capital Management reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Shaolin Capital Management sold 72,032 Celularity shares in Q3 2021, an estimated $7.33M.
  • Shaolin Capital Management first reported a position in Celularity in Q1 2020 and held it in 6 quarters.
  • Shaolin Capital Management's Celularity position peaked at $7.33M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Shaolin Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.